课题基金 / 基金详情

TREATMENT OF HERNIATED INTERVERTEBRAL DISCS WITH AUTOGENOUS CALPAIN PURIFIED FROM PATIENT'S OWN RED BLOOD CELLS

TREATMENT OF HERNIATED INTERVERTEBRAL DISCS WITH AUTOGENOUS CALPAIN PURIFIED FROM PATIENT'S OWN RED BLOOD CELLS
用从患者自身红细胞中纯化的自体钙蛋白酶治疗椎间盘突出
批准号:
10470304
负责人:
SHIMIZU Katsuji
金额:
$8.38万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

SHIMIZU Katsuji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ON THE CHEMONUCLEOLYSIS WITH CHYMOPAPAIN, COMPLICATIONS SUCH AS ANAPHYLACTIC REACTION AND PARALYSIS HAVE BEEN REPORTED. TO MEKE CHEMONUCLEOLYSIS A SAFER TREATMENT, OTHER SAFE AND POTENT ENZYMES HAVE BEEN NEEDED. AUTOGENOUS μCALPAIN AS PURIFIED FROM THE PATIENT'S OWN RED BLOOD CELLS MIGHT PRIVENT ANAPHYLACTIC REACTION. CALPAIN HAS BEEN SHOWN TO THE DEGRADATIVE ACTIVITY ON PROTEOGLYCAN OF HE INTERVERTEBRAL DISCS OF RABBITS.IN THE PRESENT STUDY, WE FOUND CEREBROSPINAL FLUID INHIBIT ENZYME REACTION OF CALPAIN IN ITS NORMAL CONCENTRAION. THE MOLECULAR WEIGHT OF CALPASTATIN, SPECIFIC ENDOGENOUS INHIBITOR OF CALPAIN, IS APPROXIMATELY 80-kDa. THE MOLECULAR WEIGHT OF THE SUBSTANCE WHICH INHIBIT CALPAIN ENZYME ACTIVITY IN CEREBROSPINAL FLUID MIGHT BE LESS THAN 10 -kDa. CEREBROSPINAL FLUID WERE SUBJECTED TO SDS-PAGE. IN THE IMMUNOBLOTTING WITH ANTICALPASTATIN ANTIBODY POSITIVE STAINING WAS NOT OBTAINED. THE SUBSTANCE WHICH INHIBIT CALPAIN IN CEREBROSPINAL FLUID MIGHT BE DIFFERENT FROM CALPASTATIN.THESE DATA SUGGEST IN CASE OF ACCIDENTAL INTRATHECAL INJECTION OF μCALPAIN FOR CHEMONUCLEOLYSIS, ITS ENZYME ACTIVITY WILL BE LOST BY CEREBROSPINAL FLUID. IT IS POSSIBLE THAT AUTOGENOUS μCALPAIN PREVENT FROM ONE OF MAJOR COMPLICATIONS SUCH AS PARALYSIS. WE SUGGEST IT MAKES CHEMONUCLEOLYSIS WITH AUTOGENOUS μCALPAIN A SAFER TREATMENT OF HENIATED INTERVERTEBRAL DISCS.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
Katsuji Shimizu: "Calpain and Its Role in Arthritis"Advances in Osteoarthritis. 134-141 (1999)
Katsuji Shimizu:“钙蛋白酶及其在关节炎中的作用”骨关节炎的进展。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hatsuji Shimizu: "Externalisation of calpain (calcium-dependent neutral cysteine proteinase) in human arthritic cartilage"Clin Exp Rhomatol. 17. 569-574 (1999)
Hatsuji Shimizu:“人关节炎软骨中钙蛋白酶(钙依赖性中性半胱氨酸蛋白酶)的外化”Clin Exp Rhomatol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Katsuji Shimizu: "Externalisation of calpain (calcium-dependent neutral cysteine proteinase) in human arthritic cartilage"Clin Exp Rhomatol. 17. 569-574 (1999)
Katsuji Shimizu:“人关节炎软骨中钙蛋白酶(钙依赖性中性半胱氨酸蛋白酶)的外化”Clin Exp Rhomatol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hatsuji Shimizu: "Calpain and its Role Arthritis"Advances in Osteoarthritis. 134-141 (1999)
Hatsuji Shimizu:“钙蛋白酶及其在关节炎中的作用”骨关节炎的进展。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
11
    PRODUCTION OF SPECIFIC MONOCLONAL ANTIBODY FOR CALPAIN CLEAVAGE SITES AND CLINICAL APPLICATION
    • 批准号:
      14370460
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.28万
    • 财政年份:
      2002
    • 负责人:
      SHIMIZU Katsuji
    • 依托单位:
    Expression of calpain on apoptosis signaling in human rheumatoid synovial cells
    • 批准号:
      12671405
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.66万
    • 财政年份:
      2000
    • 负责人:
      SHIMIZU Katsuji
    • 依托单位:
    Calpain of Synovia and synovial fluid in arthritis
    • 批准号:
      05671213
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.28万
    • 财政年份:
      1993
    • 负责人:
      SHIMIZU Katsuji
    • 依托单位:
    Biochemical Investigation on Amyloid of Ageing in Human Intervertebral Discs.
    • 批准号:
      62570681
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.47万
    • 财政年份:
      1987
    • 负责人:
      SHIMIZU Katsuji
    • 依托单位:
    国内基金
    海外基金
    Wnt5a/Calpain6/Rac1通路激活毛囊黑素干细胞逆转毛发白化的机制研究
    矢车菊素-3-O-葡萄糖苷通过miR-137-3p抑制Calpain-2/β-catenin通路降低胶质瘤细胞干性的信号机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
    • 依托单位:
    Calpain活化在线粒体稳态失衡引起噪声性耳蜗损伤中的作用机制
    • 批准号:
      82330034
    • 项目类别:
      重点项目
    • 资助金额:
      220万元
    • 批准年份:
      2023
    • 负责人:
      殷善开
    • 依托单位:
    Calpain/P-eIF2α动态平衡在黄芪甲苷IV治疗顺铂肾损伤中的机制研究
    • 批准号:
      82360738
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      32万元
    • 批准年份:
      2023
    • 负责人:
      寇温
    • 依托单位: